注重体验与质量的电子书资源下载网站
分类于: 计算机基础 人工智能
简介
Ordinary Medicine: Extraordinary Treatments, Longer Lives, and Where to Draw the Line 豆 0.0分
资源最后更新于 2020-10-26 12:12:38
作者:Sharon R. Kaufman
出版社:Duke University Press Books
出版日期:2015-01
ISBN:9780822358886
文件格式: pdf
标签: 人类学 医学 medical medi care aging MA
简介· · · · · ·
Most of us want and expect medicine’s miracles to extend our lives. In today’s aging society, however, the line between life-giving therapies and too much treatment is hard to see—it’s being obscured by a perfect storm created by the pharmaceutical and biomedical industries, along with insurance companies. In Ordinary Medicine Sharon R. Kaufman investigates what drives that sto...
目录
Acknowledgments ix
Introduction. Diagnosing Twenty-First-Century Health Care 1
Part I: The Quandry and Unexamined Ordinariness of Twenty-First-Century Medicine
1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity 21
Part II. The Chain of Health Care Drivers
2. The Medical-Industrial Complex I: Evidence-Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials 53
3. The Medical-Industrial Complex II: Access, Industry, and the Clincial Trials Phenomenon 79
4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life 99
Part III: Medicine's Changing Means and Ends
5. Standard and Necessary Treatments: The Changing Means and Ends of Technology 127
6. Family Matters: Kidneys and New Forms of Care 165
7. Influencing the Character of the Future: Prognosis, Risk, and Time Left 195
8. For Whose Benefit? Our Shared Quandary 217
Conclusion. Toward a New Social Contract? 238
Notes on the Research 249
Notes 255
Bibliography 285
Index 307
Introduction. Diagnosing Twenty-First-Century Health Care 1
Part I: The Quandry and Unexamined Ordinariness of Twenty-First-Century Medicine
1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity 21
Part II. The Chain of Health Care Drivers
2. The Medical-Industrial Complex I: Evidence-Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials 53
3. The Medical-Industrial Complex II: Access, Industry, and the Clincial Trials Phenomenon 79
4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life 99
Part III: Medicine's Changing Means and Ends
5. Standard and Necessary Treatments: The Changing Means and Ends of Technology 127
6. Family Matters: Kidneys and New Forms of Care 165
7. Influencing the Character of the Future: Prognosis, Risk, and Time Left 195
8. For Whose Benefit? Our Shared Quandary 217
Conclusion. Toward a New Social Contract? 238
Notes on the Research 249
Notes 255
Bibliography 285
Index 307